| Dr Charlene Ann Nowak, NP | |
|
500 E Veterans St, Tomah, WI 54660-3105 | |
| (608) 372-3971 | |
| Not Available |
| Full Name | Dr Charlene Ann Nowak |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Adult Health |
| Location | 500 E Veterans St, Tomah, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447835970 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QA0505X | Family Medicine - Adult Medicine | 10775-33 (Wisconsin) | Secondary |
| 363LA2200X | Nurse Practitioner - Adult Health | 10775-33 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charlene Ann Nowak, NP Po Box 1086, La Crosse, WI 54602-1086 Ph: (608) 567-9715 | Dr Charlene Ann Nowak, NP 500 E Veterans St, Tomah, WI 54660-3105 Ph: (608) 372-3971 |
News Archive
DICOM Grid, provider of a cloud-based platform for medical imaging management, today announced the general availability of DICOM Grid™ ImageCare™, the first secure, scalable cloud computing platform that makes searching, sharing and exchanging medical images as easy as using consumer web applications such as Google, Facebook and iTunes.
Panasonic Corporation ("Panasonic") and KKR, a leading global investment firm, today announced the completion of a share purchase agreement and a shareholders' agreement under which Panasonic and KKR have become joint partners of Panasonic Healthcare Co., Ltd. ("Panasonic Healthcare").
A University of Texas at Arlington electrical engineering researcher is developing a more efficient, low-power integrated circuit for directional hearing aids that will lead to a better quality of life for hearing impaired people.
Scientists from the University of Colorado Cancer Center have once again advanced the treatment of a specific kind of lung cancer. The team has documented how anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC) becomes resistant to a drug targeting the abnormal protein in the cancer. It's the first time scientists have analyzed the frequency and type of drug resistance in ALK positive patients taking crizotinib.
In the latest leg of their endless journey to find bad news about the Affordable Care Act, conservative analysts and websites have seized on some ambiguous figures to declare that enrollment is "plummeting," "shrinking," "sinking rapidly"-choose your headline. The most charitable interpretation of this claim is that it's based on extreme cherry-picking. The most accurate interpretation is that it's wrong (Michael Hiltzik, 8/13).
› Verified 4 days ago